In March 2026, the Korea International Medical & Hospital Equipment Show (KIMES) grandly opened in Seoul, South Korea. This marks OptoMedic’s second- time participation in KIMES. Compared with products at previous shows, the company unveiled its newly upgraded Stellar Endoscopic Imaging System, stepping onto the international medical stage with cutting- edge innovative technology.

As a new- generation flagship endoscopic platform, the Stellar Endoscopic Imaging System has achieved comprehensive iteration while inheriting the excellent performance of its predecessor. Retaining its proven core strengths of 4K ultra- high- definition imaging and ICG fluorescence imaging, the system is newly equipped with dual innovative functions: 3D imaging and MB fluorescence imaging. By integrating state- of- the- art endoscopic imaging technologies in one solution, it is a transformative platform type minimally invasive diagnostic and therapeutic device.

During the exhibition, the Stellar Endoscopic Imaging System drew extensive attention and received high praise from numerous surgeons worldwide for its exceptionally sharp image quality and lifelike 3D visual effects, fully demonstrating its core technical advantages and clinical value.

As an innovative Chinese- based enterprise specializing in high- end medical devices, OptoMedic consistently keeps pace with global trends in minimally- invasive therapy and focuses on independent R&D and technological breakthroughs. Going forward, the company will continue to deepen its research and development and uphold independent innovation. It will empower clinical practice with high- quality, advanced minimally- invasive medical equipment, deliver robust technical support for surgeons at home and abroad, safeguard patients’ health across the globe, and contribute to the high- quality development of worldwide minimally- invasive surgery.